3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
24
Neoplasms
12
Colonic Neoplasms
12
Breast Neoplasms
12
Prostatic Neoplasms
9
Polycythemia Vera
9
Venous Thromboembolism
8
Multiple Myeloma
8
Recurrence
5
Rectal Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Thrombocythemia, Essential
4
Ovarian Neoplasms
4
Neoplasms, Plasma Cell
4
Neoplasm Metastasis
4
Myeloproliferative Disorders
4
Barrett Esophagus
4
Precancerous Conditions
3
Melanoma
3
Esophageal Neoplasms
3
Adenomatous Polyps
3
Adenoma
3
Tobacco Use Disorder
2
Thrombosis
2
Thromboembolism
2
Smoking Cessation
2
Sarcoma
2
Primary Myelofibrosis
2
Neoplastic Cells, Circulating
2
Neoplasms by Site
2
Interventions
Ultrasonography
2
Tomography, X-Ray Computed
2
tremelimumab
1
lenvatinib
1
hepatitis C immune globulin, human
1
fluoromisonidazole
1
epigallocatechin gallate
1
durvalumab
1
babao dan
1
Vitamin B 6
1
Urination
1
Tomography
1
Tidal Volume
1
Rosuvastatin Calcium
1
Propranolol
1
Probiotics
1
Preoperative Exercise
1
Positron-Emission Tomography
1
Portasystemic Shunt, Transjugular Intrahepatic
1
Population Groups
1
Plasmapheresis
1
Oxaliplatin
1
Nadolol
1
Mebendazole
1
Introns
1
Immunoglobulin G
1
Glutathione
1
Gemcitabine
1
Furosemide
1
Everolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Liver Cirrhosis
×
Aspirin
×
Clear all
NCT07529262
2026-04-14
AspiRe HCC
Curtin University
Phase 3
Not yet recruiting
890 enrolled